Que Dallara, EVP and president of Medtronic Diabetes, wrote on LinkedIn: ...
Insulet (Nasdaq:PODD) today announced its plans to recognize National Diabetes Awareness Month and World Diabetes Day.
Abbott announced today that the FDA said users can wear the FreeStyle Libre 2 and 3 CGMs during common imaging procedures.
Beta Bionics announced today that it launched the integration of the iLet bionic pancreas with the Abbott (NYSE:ABT) ...
Insulet (Nasdaq:PODD) today announced the full market release of the Omnipod 5 automated insulin delivery app for iPhone in the U.S.
Insulcloud today announced its strategic expansion into the U.S. following FDA clearance for its Insulclock CAP smart device.
Dexcom announced today that, following the conclusion of the third quarter, it submitted its 15-day G7 CGM to the FDA.
Tidepool today announced a new data integration with Abbott for the company's FreeStyle Libre continuous glucose monitors ...